Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for blood loss during rhinoplasty
IRCT20111219008458N2Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in rhinoplasty (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Hemoglobin concentration and Blood volume in suction. Started May 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
rhinoplasty
Beyond the preview
Go deeper on IRCT20111219008458N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111219008458N2.